These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 226702)

  • 1. Cellular antiproliferative action exerted by auranofin.
    Simon TM; Kunishima DH; Vibert GJ; Lorber A
    J Rheumatol Suppl; 1979; 5():91-7. PubMed ID: 226702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of auranofin on DNA and protein synthesis in human lymphocytes.
    Finkelstein AE; Burrone OR; Walz DT; Misher A
    J Rheumatol; 1977; 4(3):245-51. PubMed ID: 336886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of a new oral gold compound on HeLa cells.
    Simon TM; Kunishima DH; Vibert GJ; Lorber A
    Cancer; 1979 Dec; 44(6):1965. PubMed ID: 389401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro boost of human NK activity by a triethylphosphine gold derivative.
    Russell AS; Nakashima S; Miller C
    Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
    Griswold DE; Lee JC; Poste G; Hanna N
    J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human immune responsiveness in vitro by auranofin.
    Salmeron G; Lipsky PE
    J Rheumatol Suppl; 1982; 8():25-31. PubMed ID: 6813487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of auranofin on absorptive processes in the rat small bowel.
    Hardcastle J; Hardcastle PT; Kelleher DK; Henderson LS; Fondacaro JD
    J Rheumatol; 1986 Jun; 13(3):541-6. PubMed ID: 2942686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism of action of gold sodium thiomalate in diseases characterized by a proliferative synovitis: reversible changes in collagen production in cultured human synovial cells.
    Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):395-403. PubMed ID: 6788936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.
    van Riel PL; Gribnau FW; van de Putte LB; Yap SH
    J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.